Coronary heart disease
171 results
1 - 100
Percutaneous coronary intervention does not improve outcomes for patients with ischemic heart disease and LVEF of less than 35%- ACP guidelines on treatment of anemia in patients with heart disease
- Polyunsaturated fat diet not effective to prevent heart disease
- Traditional approach to pretest probability of heart disease overestimates risk
- CT coronary angiography in patients with suspected CAD: no short-term benefit, increased rate of invasive angiography
- Smaller benefit of statins without heart disease
- Diabetes alone is NOT a coronary risk equivalent to a history of myocardial infarction
- Intensive lipid lowering adds additional benefit
- ACC/AHA guideline for the management of patients with chronic coronary disease
- Long-term mortality benefits with CABG for ischemic cardiomyopathy
- CABG better than PCI for patients with diabetes and multivessel CAD
- Treatment for mild hypertension is ineffective
- Subclinical hypothyroidism associated with increased risk of CHD
- No mortality benefit to CABG for patients with ischemic LV dysfunction
- Psychotherapy improves CV outcomes in at-risk patients (SUPRIM)
- A history of kidney stones increases risk of CHD in women, but not in men
- Stable ischemic heart disease diagnosis: clinical guideline
- Early invasive strategy does not reduce mortality for moderate to severe ischemic heart disease after 5.8 years (ISCHEMIA-EXTEND)
- Rotating night shift work increases risk of CHD in women
- Apolipoprotein levels no better than standard methods to evaluate CVD risk
- Clinical decision helpful in diagnosis of acute coronary syndrome in primary care
- BP lowering by any means is beneficial in most
- Omega-3 fatty acids not effective for depression in CHD patients
- Renin angiotensin system inhibitors not useful for CAD without CHF
- Coffee does not increase risk of developing CAD
- Heart and diabetes groups suggest there is little association between A1C levels and CVD risk
- ACC/AHA guidelines on dual antiplatelet therapy
- Adding CCTA to chest pain assessment reduces likelihood of nonfatal MI (SCOT-HEART)
- MDCT safe and accurate for coronary evaluation in dilated cardiomyopathy
- Migraine with aura associated with increased risk of CVD in women
- Adding coronary computed tomographic angiogram to chest pain assessment reduces likelihood of nonfatal myocardial infarction over 10 years (SCOT-HEART)
- USPSTF recommends against electrocardiography screening in low-risk adults
- Screening echocardiogram not beneficial
- ACE inhibitors effective in CAD without CHF
- Colchicine reduces myocardial infarction and revascularization in patients with established coronary disease (LoDoCo2)
- ATP-III more efficient than JUPITER
- Some older patients benefit from statin therapy
- USPSTF recommends screening for diabetes in hypertensive patients
- Many patients using warfarin also take aspirin
- Alirocumab has minimal net benefit for patients with hyperlipidemia (ODYSSEY LONG TERM)
- ACC/AHA guidelines for the diagnosis and management of atrial fibrillation
- No research to guide decisions regarding lipid disorders in younger adults
- Cholesterol lowering benefits patients at risk for CHD
- CABG not effective in patients with ischemic LV dysfunction
- USPSTF recommends against menopause hormone tx to prevent chronic conditions
- Don't add aspirin to warfarin therapy except with mechanical heart valve
- Aspirin's benefits and harms are less clear for primary prevention in moderate-risk patients (ARRIVE)
- Overuse alert: treat-to-target LDL strategy of statin dosing is noninferior to high-intensity dosing
- No difference in cognitive decline in elderly patients with coronary artery disease undergoing CABG vs PCI
- Nut consumption associated with a lower risk of many bad things
- For atrial fibrillation with stable coronary artery disease, edoxaban alone prevents more bad outcomes than edoxaban plus an antiplatelet agent
- Decreasing systolic BP to 130 or lower improves outcomes (CARDIO-CIS)
- Interpreting BNP in patients with a history of HF
- Low risk with estrogen therapy in postmenopausal women with prior hysterectomy after 10.7 years
- Rosuvastatin does not improve outcomes in HF with average lipids
- Raloxifene decreases breast CA risk, no effect on CVD risk (RUTH)
- Some benefit to treating mild hypertension to prevent stroke, CV deaths, and overall mortality
- Adding ezetimibe to moderate-dose statin reduces nonfatal MI only (NNT = 58 for 6 years)
- In patients with T2DM and CV disease, empagliflozin reduces CV and all-cause mortality (NNT = 38 over 3.3 years)
- Asymptomatic atherosclerosis found on CTA is associated with increased risk of myocardial infarction